12 May 2022 , 05:22 PM
Zim Laboratories announced today that AEPMS – The Spanish Agency for Medicine and Healthcare Products has granted Marketing Authorisation for its innovative product Sildenafil 50 mg ODS in Spain to its wholly owned European Subsidiary – SIA ZIM Laboratories. ZIM Labs is a pioneer in developing Oral Thin Films (OTF) an innovative and novel drug delivery dosage form. The above product is developed using patented Thinoral? technology,which yields instantly wettable, rapidly dissolving, and stable orally dissolving films. The conventional dosage form such as tablet and capsule are difficult to administer, may poses choking hazards and unfriendly to patient convenience. Against the odds of drug intake, oral thin film dissolves instantly after placing on the tongue and results in faster action. Unique features of OTFs and its flexibility offers unparalleled convenience in drug handling and administration. Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
